The Technology Revolution in Health Care is in Sight: Realizing an AI-driven, Compliant, Equitable, Connected Health Care Ecosystem

Partners Reed Abrahamson and Lynne Anderson will join industry leaders from Real Chemistry in a panel discussion on the accelerated speed of change in health care resulting from the adoption of novel technology, in areas such as telemedicine and decentralized clinical trials, with AI applied to everything from drug discovery to commercialization. Reed and Lynne will cover the privacy, security, legal and ethical considerations involved in moving health care forward in a measured and responsible way that does not hinder innovation.